Joe C Mathew / New Delhi July 23, 2008, 0:19 IST Boehringer Ingelheim, the $17-billion German pharma major that set up a subsidiary in India three years back, has decided to adopt a partnership model to tap the domestic market. The company is exploring collaborative research options. It will launch its entire research portfolio in the country, said Managing Director J